Tag Archives: Medtronic Infuse Lawsuit

Featured Stories
Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Exploding Tanks Kill Jeep Drivers 18 months after Recall

Exploding Gas Tanks Continue to Kill Jeep Drivers 18 months after Recall

Chrysler recalled Jeeps with exploding gas tanks more than 18 months ago, but 1 million+ of these vehicles have not been fixed as the death toll continues to rise.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two-Leading-Cancer-Groups-Issue-Call-for-Regulation-of-E-cigarettes-and-Research-on-Health-Risks

The American Society of Clinical Oncology & the American Association for Cancer Research called for government regulation & research of e-cigarettes on health effects.

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Medtronic Infuse Recipients Receive $8.45 Million in Settlements

Medtronic Infuse Recipients Win $8.45 Million in Settlements

The University of California, Los Angeles has agreed to pay a combined $8.45 million to two patients who received Medtronic’s controversial Infuse bone graft product. These individuals filed lawsuits alleging that the product caused unwanted bone growth. They also claimed … Continue reading

Posted in Defective Medical Devices, Legal News, Medtonic Infuse | Tagged , , , , , , , , , , |

Medtronic Uses Preemption in Medtronic Infuse Case, Again

Medtronic Uses Preemption in Medtronic Infuse Case, Again

The denial of review by the United States Supreme Court today in the case of Caplinger v. Medtronic, Inc., Docket No. 15-321, though it might appear to be a victory for medical device manufacturer, Medtronic, Inc., it was not. While … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse | Tagged , , , , |

INFUSE controversy causing continual decline in Medtronic’s market share

As more negativity surrounds the Medtronic INFUSE bone growth product, the company’s market share and stock value continue to decline. According to a report from Trefis.com, a stock analysis service, the recent U.S. Senate findings that Medtronic manipulated purportedly scientific … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse | Tagged , |

California Judge Rejects Medtronic Claim that Infuse Bone Graft Off-Label Marketing Lawsuit is Pre-Empted

A woman who alleges Medtronic Inc. allegedly marketed its Infuse Bone Graft product for off-label uses will be allowed to proceed with her lawsuit.  According to a report from Law360.com, a California judge rejected Medtronic’s motion for a summary judgment … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse | Tagged |

Patient Claims Medtronic Infuse, Stryker OP-1 Putty were Used Off-Label without Her Consent

A California hospital is facing scrutiny over the way patients at the facility were treated with two controversial bone growth products, Stryker’s OP-1 Putty and Medtronic Inc.’s Infuse Bone Graft.  According to a report from Mass Device.com, the California Department … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse | Tagged , |

Kentucky Lawsuit Alleges Off-Label Medtronic Infuse Procedure Left Woman Permanent, Disabling Nerve Damage

Medtronic Inc. and Kentucky hospital are facing lawsuit alleging that spinal surgery with the company’s Infuse bone graft product left a woman total disabled. The plaintiff alleges that she received the Infuse bone graft during an “unconsented, off-label surgery” at … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse | Tagged |

Medtronic Profits Down After Sprint Fidelis Defibrillator Lead Recall

Medtronic Inc., the maker of the <“http://www.yourlawyer.com/topics/overview/medtronic_defibrillators”>defective Sprint Fidelis Defibrillator Lead, said its profits have slipped 2% as a result of last month’s Sprint Fidelis recall.  To make matters worse for the company, many are now asking if Medtronic acted … Continue reading

Posted in Defective Medical Devices, Legal News, Medtronic Defibrillators | Tagged , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.